NIH-funded research Fellowship grant

Investigating how specific brain receptors affect alcohol relapse and drinking behavior

Official title: Effects of Ventral Tegmental Area Dopamine Neurons GABA-B Receptor Deletion on Cue-Evoked Relapse and Aversion-Resistant Drinking

Funded at University of Minnesota · NIH-10995566 · Data updated 2026-11-12

This study is looking at how removing certain receptors in brain cells affects drinking habits, especially when it comes to cravings and relapses, to help find better ways to treat people struggling with alcohol use.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startAugust 28, 2024
Project endAugust 27, 2028
Funding year2024
Award (this year)$36,350
NIH project number1F31AA031877-01
Project IDNIH-10995566 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of alcohol use disorder who may be at risk for relapse.

Less likely to help

Patients who do not have a history of alcohol use disorder or those who are not at risk for relapse may not benefit from this research.

What this research studies

This research focuses on understanding how the deletion of GABA-B receptors in dopamine neurons of the ventral tegmental area influences alcohol-related behaviors, particularly in the context of relapse and compulsive drinking. By using advanced techniques like CRISPR, the study aims to identify the role of these receptors in modifying responses to environmental cues that trigger alcohol consumption. Patients may benefit from insights gained about the biological mechanisms underlying alcohol use disorder, potentially leading to new treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for individuals struggling with alcohol use disorder by targeting specific brain mechanisms involved in relapse.

How similar studies have gone: Previous research has shown promising results in understanding the role of GABA-B receptors in alcohol-related behaviors, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Aguirre, Jonathan Israel — University of Minnesota
  • Study coordinator: Aguirre, Jonathan Israel

Related research

Other NIH-funded projects on the same topics.

  • Social stress and smoking: why disadvantaged young adults struggle to quit

    This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11540695

  • Learning from remission and relapse in lupus (SLE)

    Researchers are studying people with systemic lupus erythematosus who are in long-term remission without steroids or immunosuppressants to understand their immune cells, brain function, and what might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513534

  • Learning from Remission and Relapse in SLE

    A program to study people with systemic lupus erythematosus who are in long-term remission to understand immune and brain signals that might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513533

  • Alternative NF-kB activation after chemotherapy in ovarian cancer

    This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.

    NIH research San Diego State University · San Diego, United States · NIH-11473227

  • Predictors of autoimmunity onset and relapse in skin

    A study to understand what biological signals in skin predict when autoimmune diseases start, flare, or worsen in people at risk.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11471389

  • Determinants of TB Control, Relapse, and Reinfection

    A large, multi-year study aims to understand why some people who are treated for TB still have persistent infection or relapse, with the goal of improving prevention and treatment.

    NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11449646

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.